Akèy › Kansè bouch › Maryland › Baltimore

Etid klinik pou Kansè bouch nan Baltimore, MD

5 etid pou Kansè bouch ap chèche patisipan nan sit nan ak bò kote Baltimore (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment

Ap rekriteFaz 3

University of Maryland/Greenebaum Cancer Center, Baltimore

Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT06589804

Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer

Ap rekriteFaz 1

University of Maryland/Greenebaum Cancer Center, Baltimore

Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT05172245

Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery

Ap rekriteFaz 2

Greater Baltimore Medical Center, Baltimore

Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT02734537

Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer

Ap rekriteFaz 2

Greater Baltimore Medical Center, Baltimore

Laj 18 ak plis · Tout sèks · Mizajou Aug 17, 2026 · NCT06532279

Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-escalation (NeoScorch HN)

Ap rekriteFaz 2

Johns Hopkins Hospital East Baltimore, Baltimore

Laj 18 ak plis · Tout sèks · Mizajou Apr 23, 2026 · NCT07209189

Etid Kansè bouch nan lòt vil

Lòt etid nan Baltimore

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.